Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...

Former DeepMind scientist Simon Kohl has raised $50 million for Latent Labs, a London-based AI startup aiming to transform ...

The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics ...

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

Feel like there are already a lot of store closing announcements in 2025? Here's a list of retailers closing stores in and ...

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...